MedTrace Logo

TRIAD Appendicitis Decision-making Surveys

NCT05887414 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2023-06-18

No results posted yet for this study

Summary

While appendectomy has been the main treatment of appendicitis for over 100 years, recent European studies found that, at least among highly selected patients, antibiotics alone can be an effective alternative. Surgeons and patients alike have a difficult time deciding if surgery or antibiotics are the best choice to treat appendicitis. The goal of the TRIAD is to evaluate the patients who are a part of the TRIAD implementation program and assess satisfaction and decisional regret for patients with appendicitis. This information will be used to inform the design of decision-support interventions to help patients improve their ability to make an informed decision in-line with their preferences and values.

Conditions

  • Appendicitis

Interventions

OTHER

Baseline

Measure Ottawa Decisional Regret at baseline when patients receive a diagnosis of appendicitis.

OTHER

30 Day Follow Up

Measure Ottawa Decisional Regret after 30 days.

Sponsors & Collaborators

Principal Investigators

  • Giana Davidson, MD, MPH · University of Washington

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-10-01
Completion
2025-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05887414 on ClinicalTrials.gov